The hiring of a former top FDA official amplifies "revolving door" criticism at the worst possible time, STAT's Adam ...

As the second Trump administration settles in, the U.S.' top pharmaceutical trade group is drafting its ambitions for the ...

Greek-American Pfizer CEO Dr Albert Bourla faced an unwelcoming reception at the White House during an event celebrating ...

President Trump also refused to promise pharma execs that he would hamstring the IRA’s drug negotiation program.

Pfizer on Monday named the former head of the U.S. health regulator's drug evaluation unit, Patrizia Cavazzoni, as its chief ...

A study by KFF found that one in four Republican parents now say they've skipped or delayed some childhood vaccines as of January 2025.

Pfizer is vulnerable to the possibility that President Donald Trump will place tariffs on the European Union, where the ...

Pfizer has signed a deal with Summit Therapeutics to assess the efficacy of Summit’s ivonescimab in combination with several ...